Olivier Brandicourt - May 1, 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
4
Date filed
5/2/2025, 04:28 PM
Previous filing
Jun 7, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BRANDICOURT OLIVIER Director C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact 2025-05-02 0001508518

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +40.1K $0.00 40.1K May 1, 2025 Common Stock 40.1K $35.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on May 1, 2026 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.